Giant Biogene Holding Co., Ltd. (2367.HK)

HKD 76.2

(0.26%)

Market Cap (In HKD)

77.91 Billion

Revenue (In HKD)

3.52 Billion

Net Income (In HKD)

1.45 Billion

Avg. Volume

3.86 Million

Currency
HKD
Country
Consumer Defensive
Open
-
Prev. Close
-
Day Range
-
Year Range
28.75-58.0
PE
34.79
EPS
2.19
Beta Value
0.666
ISIN
KYG3887G1091
CUSIP
CIK
-
Shares
1022542399.0
Earnings Annoncement
-

Company Profile

Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Mr. Jianya Yan
Employee Count
-
Website
https://www.xajuzi.com
Ipo Date
2022-11-04
Details
Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.